No Appeal of LDT/FDA Lawsuit

No Appeal of LDT/FDA Lawsuit

The FDA had until May 30 to appeal U.S. District Court Judge Sean D. Jordan's decision to vacate the agency's Final Rule seeking to regulate laboratory developed tests (LDTs). The federal government declined to appeal the judge's decision meaning the Texas District Court's decision to vacate, in its entirety, the FDA's attempt to regulate LDTs as medical devices stands.

Read ACLA’s full lawsuit.

Read the Final Judgment.

 

Trump Administration Imposes Temporary Import Duties Following Supreme Court Ruling

Trump Administration Imposes Temporary Import Duties Following Supreme Court Ruling

Despite recent legal challenges to the Trump administration’s sweeping tariffs, a Section 232 investigation is ongoing for imports of medical...

Read More
UHC Routine Testing Management Policies to Be Implemented in Three More States in April

UHC Routine Testing Management Policies to Be Implemented in Three More States in April

UnitedHealthcare (UHC) is now implementing new Routine Testing Management Policies for laboratory services, tests, and procedures in North Carolina,...

Read More
TELCOR Sponsors Sonic Medical Leadership Summit 2026

TELCOR Sponsors Sonic Medical Leadership Summit 2026

Lincoln, Nebraska – February 24, 2026 – TELCOR Inc is proud to be an Ultimate Diamond Partner of the Sonic Healthcare USA Medical Leadership Summit, ...

Read More